Division of Bio-Function Dynamics Imaging, RIKEN Center for Life Science Technologies (CLST), 6-7-3 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
Takeda Pharmaceutical Company Limited, 12-10 Nihonbashi 2-Chome, Chuo-ku, Tokyo, 103-8668, Japan.
Mol Imaging Biol. 2018 Dec;20(6):1001-1007. doi: 10.1007/s11307-018-1186-y.
Thiamine is an essential component of glucose metabolism and energy production. The disulfide derivative, thiamine tetrahydrofurfuryl disulfide (TTFD), is better absorbed than readily-available water-soluble thiamine salts because it does not require the rate-limiting transport system required for thiamine absorption. However, the detailed pharmacokinetics of thiamine and TTFD under normal and pathological conditions have not yet been clarified. C-11-labeled thiamine and TTFD were recently synthesized by our group. In this study, to clarify the differences in pharmacokinetics and metabolism of these probes, a quantitative PET imaging study and radiometabolite analysis of C-11-labeled thiamine and TTFD were performed in the rat heart.
Positron emission tomography (PET) imaging with [C]thiamine and [C]TTFD was performed in normal rats to determine the pharmacokinetics of these probes, and the radiometabolites of both probes from the blood and heart tissue were analyzed by thin-layer chromatography.
Accumulation of [C]TTFD was significantly higher than that of [C]thiamine in the rat heart. Moreover, as a result of the radiometabolite analysis of heart tissue at 15 min after the injection of [C]TTFD, thiamine pyrophosphate, which serves as a cofactor for the enzymes involved in glucose metabolism, was found as the major radiometabolite and at a significantly higher level than in the [C]thiamine-injected group.
PET imaging techniques for visualizing the kinetics and metabolism of thiamine using [C]thiamine and [C]TTFD were developed in this study. Consequently, noninvasive PET imaging for the pathophysiology of thiamine-related cardiac function may provide novel information about heart failure and related disorders.
硫胺素是葡萄糖代谢和能量产生的必需组成部分。二硫化物衍生物,即噻唑四氢呋喃二硫化物(TTFD),比易于获得的水溶性硫胺素盐更易被吸收,因为它不需要硫胺素吸收所需的限速转运系统。然而,正常和病理条件下硫胺素和 TTFD 的详细药代动力学尚未阐明。我们小组最近合成了 C-11 标记的硫胺素和 TTFD。在这项研究中,为了阐明这些探针在药代动力学和代谢方面的差异,我们在大鼠心脏中进行了 C-11 标记的硫胺素和 TTFD 的定量 PET 成像研究和放射性代谢产物分析。
在正常大鼠中进行正电子发射断层扫描(PET)成像,以确定这些探针的药代动力学,并通过薄层层析分析来自血液和心脏组织的两种探针的放射性代谢产物。
与 [C]硫胺素相比,[C]TTFD 在大鼠心脏中的积累明显更高。此外,由于在注射 [C]TTFD 后 15 分钟对心脏组织进行的放射性代谢产物分析,发现焦磷酸硫胺素(作为参与葡萄糖代谢的酶的辅酶)是主要的放射性代谢产物,并且水平明显高于 [C]硫胺素注射组。
本研究开发了使用 [C]硫胺素和 [C]TTFD 可视化硫胺素动力学和代谢的 PET 成像技术。因此,非侵入性的 PET 成像可能为与硫胺素相关的心脏功能的病理生理学提供有关心力衰竭和相关疾病的新信息。